For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Bisacodyl - Constipation
PAD Profile : Bisacodyl - Constipation
Traffic Light Status
Status 1 of 2.
- Suppositories
- Tablets
Status 2 of 2.
- Not Specified
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Macrogol 3350
- Methylnaltrexone bromide
- Prucalopride
- Naloxegol
- Ispaghula husk
- Docusate sodium
- Glycerol
- Senna
- Lactulose
- Phosphates (Rectal)
- Sterculia
- Co-danthrusate (Dantron/docusate sodium)
- Co-danthramer (Dantron/poloxamer 188)
- Sodium citrate (Rectal)
- Naldemedine
- Arachis oil
- Magnesium hydroxide
- Sodium picosulfate
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.
Management | Constipation | CKS | NICE
The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.
Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.
NOTE - In October 2019 bisacodyl 7.5mg suppositories (Aralax) are NOT locally recommended. They are unlicensed and have been assigned a NON FORMULARY traffic light status. For more information visit the Aralax profile on PAD. https://surreyccg.res-systems.net/PAD/Search/DrugConditionProfile/4822